Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer
- PMID: 15930309
- DOI: 10.1158/0008-5472.CAN-04-3028
Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer
Abstract
Apoptosis levels have been shown to predict tumor response to preoperative radiochemotherapy in rectal cancer. Recently, the prominent role of survivin, a structurally unique member of the inhibitor of apoptosis protein family, has been shown in colorectal cancer tumorigenesis and prognosis. In this study, we investigated whether survivin plays a direct role in mediating radiation resistance. We used short interfering RNA molecules to decrease survivin in radioresistant SW480 and intermediately radioresistant HCT-15 colorectal cancer cells. This resulted in a significant decrease of survivin mRNA and protein expression with a maximum at 24 to 48 hours after transfection. If irradiated during this sensitive period, an increased percentage of apoptotic cells and an increased caspase 3/7 activity in parallel with a decreased cell viability and a reduced clonogenic survival was shown. These effects were more pronounced in the radioresistant SW480 cell line with a radiation-induced cytotoxicity enhancement factor at 10% and 50% survival of 1.8 to 2.2 for SW480 and 1.5 to 1.7 for HCT-15, respectively. Furthermore, transfection with survivin short interfering RNA increased levels of G2-M arrest and levels of DNA double-strand breaks in irradiated cells. These observations indicate that cell cycle and DNA repair mechanisms may be associated with apoptosis induction in tumor cells that are otherwise resistant to killing by radiation. In a translational study of 59 patients with rectal cancer treated with a combination of radiotherapy and chemotherapy, increased survivin expression was inversely related to the levels of apoptosis, and was also associated with a significantly higher risk of a local tumor recurrence.
Similar articles
-
Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.Cancer Res. 2006 May 1;66(9):4952-60. doi: 10.1158/0008-5472.CAN-05-3918. Cancer Res. 2006. PMID: 16651453
-
Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.Surgery. 2005 Aug;138(2):299-305. doi: 10.1016/j.surg.2005.05.009. Surgery. 2005. PMID: 16153440
-
Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.Cancer. 2006 Aug 15;107(4):746-56. doi: 10.1002/cncr.22044. Cancer. 2006. PMID: 16826583
-
The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target.Strahlenther Onkol. 2007 Nov;183(11):593-9. doi: 10.1007/s00066-007-1800-4. Strahlenther Onkol. 2007. PMID: 17960333 Review.
-
Survivin, versatile modulation of cell division and apoptosis in cancer.Oncogene. 2003 Nov 24;22(53):8581-9. doi: 10.1038/sj.onc.1207113. Oncogene. 2003. PMID: 14634620 Review.
Cited by
-
KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression.Cell Prolif. 2013 Aug;46(4):425-35. doi: 10.1111/cpr.12043. Cell Prolif. 2013. PMID: 23869764 Free PMC article.
-
A review of preoperative chemoradiotherapy for lower rectal cancer.J Anus Rectum Colon. 2018 May 25;1(3):65-73. doi: 10.23922/jarc.2017-013. eCollection 2017. J Anus Rectum Colon. 2018. PMID: 31583303 Free PMC article. Review.
-
Prognostic significance of nuclear survivin expression in resected adenoid cystic carcinoma of the head and neck.Head Neck Oncol. 2010 Oct 30;2:30. doi: 10.1186/1758-3284-2-30. Head Neck Oncol. 2010. PMID: 21034499 Free PMC article.
-
Effect of hypoxia-inducible factor-1alpha on transcription of survivin in non-small cell lung cancer.J Exp Clin Cancer Res. 2009 Feb 26;28(1):29. doi: 10.1186/1756-9966-28-29. J Exp Clin Cancer Res. 2009. PMID: 19245702 Free PMC article.
-
Increased spontaneous apoptosis, but not survivin expression, is associated with histomorphologic response to neoadjuvant chemoradiation in rectal cancer.Int J Colorectal Dis. 2009 Nov;24(11):1261-9. doi: 10.1007/s00384-009-0755-6. Epub 2009 Jul 11. Int J Colorectal Dis. 2009. PMID: 19593573
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials